Chang-Ming Wang

Chang-Ming Wang

Auto-generated profile, based on publicly available information

Chang-Ming Wang

Division of Respiratory Diseases, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, People's Republic of China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
WLWeijia Liao
Weijia Liao
GHGuojin Huang
Guojin Huang
YLYan Liao
Yan Liao
JYJianjun Yang
Jianjun Yang
QCQian Chen
Qian Chen
CWChangming Wang
Changming Wang
This study aimed to investigate KIF18A expression in hepatocellular carcinoma (HCC) and to determine the possibility of KIF18A expression being a biomarker in HCC diagnosis or being an independent predictor of disease-free survival (DFS) and overall survival (OS) in HCC patients underwent surgical resection. KIF18AmRNA was detected in 216 cases of HCC tissues by quantitative real-time PCR (qRT-PCR) and in 20 cases of HCC tissues by semi-quantitative RT-PCR. KIF18A protein was determined in 32 cases of HCC tissues by immunohistochemistry (IHC). The survival probability was analyzed by Kaplan-Meier method, and survival curves between groups were obtained by using the log-rank test. Independent predictors associated with DFS were analyzed with Stepwise Cox proportional hazard models. High KIF18A mRNA level was detected in 154 out of 216 (71.3%) cases of HCC. The positive rate of KIF18A expression was significantly higher in liver cancer tissues than that in adjacent normal liver tissues (ANLT) from HCC patients [65.6% (21 of 32) vs. 25.0% (8 of 32), P=0.001]. The KIF18A expression level had positive relevance to the alpha-fetoprotein (AFP) (≥200 ng/ml), tumor size (≥5cm), clinical tumor-node-metastasis (TNM) stage and portal vein tumor thrombus (PVTT) in HCC (all P <0.05). A survival analysis indicated that HCC patients with higher KIF18A expression had a significantly shorter DFS and OS after resection. A multivariate analysis suggested that KIF18A upregualtion was an independent factor for DFS [hazard risk (HR)=1.602; 95% confidence interval (CI), 1.029-2.579; P=0.031] and OS (HR=1.682; 95% CI, 1.089-2.600; P=0.019). KIF18A might be a biomarker for HCC diagnosis and an independent predictor of DFS and OS after surgical resection.

17 March 2012 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
CWChangming Wang
Changming Wang
XXXiuping Xuan
Xiuping Xuan
WYWenmin Yao
Wenmin Yao
GHGuojin Huang
Guojin Huang
JJJunfei Jin
Junfei Jin
The present study aimed to determine whether artesunate has beneficial effects on bleomycin-induced pulmonary fibrosis in rats and to examine the possible mechanisms underlying these effects. All experiments were performed with male Sprague Dawley rats weighing 180-250 g. Animals were randomly divided into four experimental groups that were administered either saline alone, artesunate alone, bleomycin alone or bleomycin + artesunate. Lung histopathology was investigated by hematoxylin and eosin staining and Masson staining. Lung profibrotic molecules were analyzed by reverse transcription polymerase chain reaction, immunoblotting and immunohistochemistry. In rats treated with artesunate, pulmonary fibrosis induced by bleomycin was significantly reduced. Administration of artesunate significantly improved bleomycin-induced morphological alterations. Profibrotic molecules, including transforming growth factor-β1, Smad3, heat shock protein 47, α-smooth muscle actin and collagen type I were also reduced by artesunate. These findings suggest that artesunate improves bleomycin-induced pulmonary fibrosis pathology in rats possibly by inhibiting profibrotic molecules associated with pulmonary fibrosis.

17 May 2013 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
LLLao-Dong Li
Lao-Dong Li
HYHuina Yu
Huina Yu
XWXiaoyang Wang
Xiaoyang Wang
JZJinrong Zeng
Jinrong Zeng
DLDangyu Li
Dangyu Li
BMBiwen Mo
Biwen Mo
Background: Previous reports have suggested that malignant transformations originate from adult stem cells, and may thus express the stem-cell-associated markers. The purpose of this study is to investigate the differential expression and clinical significance of seven stem-cell-associated markers (Bmi1, CD133, CD44, Sox2, Nanog, OCT4 and Msi2) in lung cancer, providing new targets for the diagnosis and treatment of lung cancer. Methods: In this study, we evaluated the differential expression of mRNA levels seven stem-cell-associated markers by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) from 112 human lung cancer and 18 non-cancer tissues obtained by bronchoscopy. We further verified the differential expression of these markers by immunohistochemistry in 50 lung cancer specimens, 30 benign inflammatory lesion tissues and 20 non-tumor adjacent lung tissues. Results: With the exception of OCT4, other markers Bmi1, CD133, CD44, Sox2, Nanog and Msi2 mRNA and protein were abundantly expressed in lung cancer. Additionally, Nanog expression was highly upregulated in lung cancer tissues and rarely presented in non-cancerous lung tissues, the sensitivity and specificity of Nanog mRNA reached 63.4% and 66.7%, respectively. Nanog therefore possessed high diagnostic value, however, CD44, Bmi1 and CD133 showed poor diagnostic value in lung cancer. Conclusion: Nanog may serve as a promising diagnostic marker of lung cancer and potential therapeutic target in lung cancer.

1 January 2015
Verified
Journal Article
Closed access
BMBiwen Mo
Biwen Mo
JLJie Li
Jie Li
JWJianghong Wei
Jianghong Wei
CWChangming Wang
Changming Wang
JZJinrong Zeng
Jinrong Zeng
JHJianwei Huang
Jianwei Huang

1 November 2010
Verified
Journal Article
Closed access
BMBi-Wen Mo
Bi-Wen Mo
JWJiang-Hong Wei
Jiang-Hong Wei
JHJian-Wei Huang
Jian-Wei Huang
CWChang-Ming Wang
Chang-Ming Wang
JZJin-Rong Zeng
Jin-Rong Zeng
YLYun Lin
Yun Lin

1 August 2003
Verified
Journal Article
Closed access
JZJin-Rong Zeng
Jin-Rong Zeng
CWChang-Ming Wang
Chang-Ming Wang
YZYan Zeng
Yan Zeng
BMBi-Wen Mo
Bi-Wen Mo
HHHui Huang
Hui Huang